Our CTO Luke Pase is at Allogeneic Cell Therapies Summit in Boston  leading the pre-conference workshop “Innovating the Future of Cell Therapy with Next Generation Gene Editing” placing a spotlight on what has been deemed the ‘future of cell therapy’

Reach out to us if you would like to meet.


< Back to newsroom